Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye disease with innovative small molecules to preserve, slow, or restore vision loss.
Company Profile
Industry Classifications
Sector
Healthcare
Industry
Biotechnology
SIC
2834 - Pharmaceutical Preparations
Contact Information
Investor Relations
Company Contact
Kiora Pharmaceuticals, Inc.
169 Saxony Rd
Suite 212
Encinitas, CA 92024